相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma
N. Nohata et al.
BRITISH JOURNAL OF CANCER (2013)
HDAC6 promotes hepatocellular carcinoma progression by inhibiting P53 transcriptional activity
Gang Ding et al.
FEBS LETTERS (2013)
Epigenetic silencing of Bcl-2, CEBPA and p14ARF by the AML1-ETO oncoprotein contributing to growth arrest and differentiation block in the U937 cell line
Wen-Yue Zhuang et al.
ONCOLOGY REPORTS (2013)
SPRR2A enhances p53 deacetylation through HDAC1 and down regulates p21 promoter activity
Yoshiaki Mizuguchi et al.
BMC MOLECULAR BIOLOGY (2012)
Valproic acid triggers differentiation and apoptosis in AML1/ETO-positive leukemic cells specifically
Michal Zapotocky et al.
CANCER LETTERS (2012)
Impairment of p53 acetylation by EWS-Fli1 chimeric protein in Ewing Family Tumors
Yan Li et al.
CANCER LETTERS (2012)
Identification of an acetylation-dependant Ku70/FLIP complex that regulates FLIP expression and HDAC inhibitor-induced apoptosis
E. Kerr et al.
CELL DEATH AND DIFFERENTIATION (2012)
HDAC5 is required for maintenance of pericentric heterochromatin, and controls cell-cycle progression and survival of human cancer cells
P. Peixoto et al.
CELL DEATH AND DIFFERENTIATION (2012)
Acetylation modulates the STAT signaling code
Martin Wieczorek et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2012)
Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer
Ali Aghdassi et al.
GUT (2012)
The role of sirtuin 2 activation by nicotinamide phosphoribosyltransferase in the aberrant proliferation and survival of myeloid leukemia cells
Lan Dan et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
HDAC2 overexpression confers oncogenic potential to human lung cancer cells by deregulating expression of apoptosis and cell cycle proteins
Kwang Hwa Jung et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Combining microRNA-449a/b with a HDAC inhibitor has a synergistic effect on growth arrest in lung cancer
Hyo Sung Jeon et al.
LUNG CANCER (2012)
RUNX3-mediated transcriptional inhibition of Akt suppresses tumorigenesis of human gastric cancer cells
F-C Lin et al.
ONCOGENE (2012)
HDAC1 Inactivation Induces Mitotic Defect and Caspase-Independent Autophagic Cell Death in Liver Cancer
Hong Jian Xie et al.
PLOS ONE (2012)
The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop
Antje Menssen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Involvement of HDAC1 in E-cadherin expression in prostate cancer cells; its implication for cell motility and invasion
Nam Hyun Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Sirtuin-3 (SIRT3), a Novel Potential Therapeutic Target for Oral Cancer
Turki Y. Alhazzazi et al.
CANCER (2011)
SIRT2 Maintains Genome Integrity and Suppresses Tumorigenesis through Regulating APC/C Activity
Hyun-Seok Kim et al.
CANCER CELL (2011)
Combined inhibition of DNA methyltransferase and histone deacetylase restores caspase-8 expression and sensitizes SCLC cells to TRAIL
Vitaliy O. Kaminskyy et al.
CARCINOGENESIS (2011)
HDAC4 Protein Regulates HIF1α Protein Lysine Acetylation and Cancer Cell Response to Hypoxia
Hao Geng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
A Novel Epigenetic Phenotype Associated With the Most Aggressive Pathway of Bladder Tumor Progression
Celine Vallot et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Molecular marks for epigenetic identification of developmental and cancer stem cells
Samir Kumar Patra et al.
CLINICAL EPIGENETICS (2011)
Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells
Praveen Rajendran et al.
CLINICAL EPIGENETICS (2011)
Elucidating the Mechanism of Regulation of Transforming Growth Factor β Type II Receptor Expression in Human Lung Cancer Cell Lines
Sunil K. Halder et al.
NEOPLASIA (2011)
HDAC6 Deacetylates Ku70 and Regulates Ku70-Bax Binding in Neuroblastoma
Chitra Subramanian et al.
NEOPLASIA (2011)
Anticancer Therapy SMRT-ens Up: Targeting the BCL6-SMRT Interaction in B Cell Lymphoma
Leigh A. Compton et al.
CANCER CELL (2010)
SIRT3 Is a Mitochondria-Localized Tumor Suppressor Required for Maintenance of Mitochondrial Integrity and Metabolism during Stress
Hyun-Seok Kim et al.
CANCER CELL (2010)
The Histone Deacetylase Sirt6 Regulates Glucose Homeostasis via Hif1α
Lei Zhong et al.
CELL (2010)
Claudin-1 Has Tumor Suppressive Activity and Is a Direct Target of RUNX3 in Gastric Epithelial Cells
Ti Ling Chang et al.
GASTROENTEROLOGY (2010)
Combined proteasome and histone deacetylase inhibition attenuates epithelial-mesenchymal transition through E-cadherin in esophageal cancer cells
Matthew D. Taylor et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2010)
The Cyclin-Dependent Kinase Inhibitor p21 Is a Crucial Target for Histone Deacetylase 1 as a Regulator of Cellular Proliferation
Gordin Zupkovitz et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
HDAC2 attenuates TRAIL-induced apoptosis of pancreatic cancer cells
Susanne Schueler et al.
MOLECULAR CANCER (2010)
MS-275 Sensitizes TRAIL-Resistant Breast Cancer Cells, Inhibits Angiogenesis and Metastasis, and Reverses Epithelial-Mesenchymal Transition In vivo
Rakesh K. Srivastava et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Acetylation modulates prolactin receptor dimerization
Li Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The use of human tissue in epidemiological research; ethical and legal considerations in two biobanks in Belgium
Carla Truyers et al.
MEDICINE HEALTH CARE AND PHILOSOPHY (2010)
Trichostatin A-Induced TGF-β Type II Receptor Expression in Retinoblastoma Cell Lines
Yoshiko Kashiwagi et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection
Nanda Burger-van Paassen et al.
BIOCHEMICAL JOURNAL (2009)
Chemical mechanisms of histone lysine and arginine modifications
Brian C. Smith et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2009)
The expression and significance of HIF-1α and GLUT-3 in glioma
Yang Liu et al.
BRAIN RESEARCH (2009)
HDAC family: What are the cancer relevant targets?
Olaf Witt et al.
CANCER LETTERS (2009)
SIRT6 Links Histone H3 Lysine 9 Deacetylation to NF-κB-Dependent Gene Expression and Organismal Life Span
Tiara L. A. Kawahara et al.
CELL (2009)
Histone Deacetylase 8 in Neuroblastoma Tumorigenesis
Ina Oehme et al.
CLINICAL CANCER RESEARCH (2009)
E-Cadherin Regulates Metastasis of Pancreatic Cancer In Vivo and Is Suppressed by a SNAIL/HDAC1/HDAC2 Repressor Complex
Johannes von Burstin et al.
GASTROENTEROLOGY (2009)
HDAC2 mediates therapeutic resistance of pancreatic cancer cells via the BH3-only protein NOXA
P. Fritsche et al.
GUT (2009)
Reactivation of death receptor 4 (DR4) expression sensitizes medulloblastoma cell lines to TRAIL
Dolly G. Aguilera et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice
Sharmila Shankar et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner
Frederic Van Gool et al.
NATURE MEDICINE (2009)
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
Michael Haberland et al.
NATURE REVIEWS GENETICS (2009)
HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism
D. Mottet et al.
ONCOGENE (2009)
miR-449a targets HDAC-1 and induces growth arrest in prostate cancer
E. J. Noonan et al.
ONCOGENE (2009)
Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
Chunaram Choudhary et al.
SCIENCE (2009)
HDAC6 inhibition enhances 17-AAG-mediated abrogation of hsp90 chaperone function in human leukemia cells
Rekha Rao et al.
BLOOD (2008)
Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy
W. Weichert et al.
BRITISH JOURNAL OF CANCER (2008)
RUNX3 attenuates β-catenin/T cell factors in intestinal tumorigenesis
Kosei Ito et al.
CANCER CELL (2008)
Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice
Rui-Hong Wang et al.
CANCER CELL (2008)
Repression of 15-Hydroxyprostaglandin Dehydrogenase Involves Histone Deacetylase 2 and Snail in Colorectal Cancer
Michael G. Backlund et al.
CANCER RESEARCH (2008)
HDAC4 Promotes Growth of Colon Cancer Cells via Repression of p21
Andrew J. Wilson et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
Competitive or noncompetitive, that's the question: research toward histone deacetylase inhibitors
Hong Su et al.
MOLECULAR CANCER THERAPEUTICS (2008)
HDAC3 overexpression and colon cancer cell proliferation and differentiation
Colleen C. Spurling et al.
MOLECULAR CARCINOGENESIS (2008)
Epigenetic interplay between histone modifications and DNA methylation in gene silencing
Thomas Vaissiere et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2008)
Concordant epigenetic silencing of transforming growth factor-β signaling pathway genes occurs early in breast carcinogenesis
Rebecca A. Hinshelwood et al.
CANCER RESEARCH (2007)
Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells
A. Vincent et al.
ONCOGENE (2007)
Histone deacetylase inhibitors: Overview and perspectives
Milos Dokmanovic et al.
MOLECULAR CANCER RESEARCH (2007)
Role for histone deacetylase 1 in human tumor cell proliferation
Silvia Senese et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Targeting AML1/ETO-histone deacetylase repressor complex: A novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells
Shujun Liu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
被撤回的出版物: Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation (Retracted article. See vol. 78, pg. 4097, 2018)
Chang-Shi Chen et al.
CANCER RESEARCH (2007)
The short chain fatty acid, butyrate, stimulates MUC2 mucin production in the human colon cancer cell line, LS174T
Hajime Hatayama et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Histone deacetylase 2 modulates p53 transcriptional activities through regulation of p53-DNA binding activity
Kelly Lynn Harms et al.
CANCER RESEARCH (2007)
Discovery and development of SAHA as an anticancer agent
P. A. Marks
ONCOGENE (2007)
An acetylation site in the middle domain of Hsp90 regulates chaperone function
Bradley T. Scroggins et al.
MOLECULAR CELL (2007)
Metabolism, cytoskeleton and cellular signalling in the grip of protein N-epsilon- and O-acetylation
Xiang-Jiao Yang et al.
EMBO REPORTS (2007)
Acetylation of GATA-1 is required for chromatin occupancy
Janine M. Lamonica et al.
BLOOD (2006)
Epigenetic regulation of tumor endothelial cell anergy:: Silencing of intercellular adhesion molecule-1 by histone modifications
Debby M. E. I. Hellebrekers et al.
CANCER RESEARCH (2006)
MUC2 expression is regulated by histone H3 modification and DNA methylation in pancreatic cancer
Norishige Yamada et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Peroxisome proliferator-activated receptor γ regulates E-cadherin expression and inhibits growth and invasion of prostate cancer
Jean-Sebastien Annicotte et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Valproate inhibition of histone deacetylase 2 affects differentiation and decreases proliferation of endometrial stromal sarcoma cells
Andelko Hrzenjak et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1α
David Z. Qian et al.
CANCER RESEARCH (2006)
The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL
Lisa M. Butler et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Targeting histone deacetylase in cancer therapy
Hsiang-Yu Lin et al.
MEDICINAL RESEARCH REVIEWS (2006)
Histone deacetylase 3 (HDAC3) and other class IHDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer
AJ Wilson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis
RN Saha et al.
CELL DEATH AND DIFFERENTIATION (2006)
Histone H4-K16 acetylation controls chromatin structure and protein interactions
M Shogren-Knaak et al.
SCIENCE (2006)
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
S Minucci et al.
NATURE REVIEWS CANCER (2006)
In vitro assays for the determination of histone deacetylase activity
B Heltweg et al.
METHODS (2005)
Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90 - A novel basis for antileukemia activity of histone deacetylase inhibitors
P Bali et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer
S Saji et al.
ONCOGENE (2005)
HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor
JJ Kovacs et al.
MOLECULAR CELL (2005)
Regulation of tissue-specific and extracellular matrix-related genes by a class I histone deacetylase
JR Whetstine et al.
MOLECULAR CELL (2005)
Increased expression of historic deacetylase 2 is found in human gastric cancer
J Song et al.
APMIS (2005)
Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1/WAF1 expression, independent of histone deacetylase 1
BH Huang et al.
CELL DEATH AND DIFFERENTIATION (2005)
Ku70 acetylation mediates neuroblastoma cell death induced by histone deacetylase inhibitors
C Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Activation of Stat3 sequence-specific DNA binding and transcription by p300/CREB-binding protein-mediated acetylation
R Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Trichostatin a induces transforming growth factor ß type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1•NF-Y complex
WQ Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas
H Duan et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Stat3 dimerization regulated by reversible acetylation of a single lysine residue
ZL Yuan et al.
SCIENCE (2005)
Upregulation and nuclear recruitment of HDACI in hormone refractory prostate cancer
K Halkidou et al.
PROSTATE (2004)
Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase
A Brunet et al.
SCIENCE (2004)
Active repression of antiapoptotic gene expression by ReIA(p65) NF-κB
KJ Campbell et al.
MOLECULAR CELL (2004)
Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo
JY Luo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
ETO protein of t(8;21) AML is a corepressor for Bcl-6 B-cefl lymphorna oncoprotein
N Chevallier et al.
BLOOD (2004)
6-phosphofructo-2-kinase (pfkfb3) gene promoter contains hypoxia-inducible factor-1 binding sites necessary for transactivation in response to hypoxia
M Obach et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Restoration of transforming growth factor-β signaling through receptor RI induction by histone deacetylase activity inhibition in breast cancer cells
S Ammanamanchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase
HY Cohen et al.
SCIENCE (2004)
Transforming growth factor-β stimulates p300-dependent RUNX3 acetylation, which inhibits ubiquitination-mediated degradation
YH Jin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Trichostatin A - like hydroxamate histone deacetylase inhibitors as therapeutic agents: Toxicological point of view
T Vanhaecke et al.
CURRENT MEDICINAL CHEMISTRY (2004)
Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex
H Peinado et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Reduced expression of class II histone deacetylase genes is associated with poor prognosis in lung cancer patients
H Osada et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis
P Zhu et al.
CANCER CELL (2004)
Altered interaction of HDAC5 with GATA-1 during MEL cell differentiation
K Watamoto et al.
ONCOGENE (2003)
Antitumor efficacy of FK228, a novel histone deacetylase inhibitor, depends on the effect on expression of anglogenesis factors
Y Sasakawa et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Epigenetic consequences of AML1-ETO action at the human c-FMS locus
GA Follows et al.
EMBO JOURNAL (2003)
The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene
G Lagger et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase
BJ North et al.
MOLECULAR CELL (2003)
A homogeneous nonisotopic histone deacetylase activity assay
B Heltweg et al.
JOURNAL OF BIOMOLECULAR SCREENING (2003)
Identification of novel isoform-selective inhibitors within class I histone deacetylases
ED Hu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
The inv(16) fusion protein associates with corepressors via a smooth muscle myosin heavy-chain domain
KL Durst et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
A fluorogenic histone deacetylase assay well suited for high-throughput activity screening
D Wegener et al.
CHEMISTRY & BIOLOGY (2003)
In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation
A Matsuyama et al.
EMBO JOURNAL (2002)
Acetylation of ReIA at discrete sites regulates distinct nuclear functions of NF-κB
LF Chen et al.
EMBO JOURNAL (2002)
Acetylation inactivates the transcriptional repressor BCL6
OR Bereshchenko et al.
NATURE GENETICS (2002)
The t(8;21) fusion protein, AML1-ETO, specifically represses the transcription of the p14ARF tumor suppressor in acute myeloid leukemia
B Linggi et al.
NATURE MEDICINE (2002)
Class II histone deacetylases are directly recruited by BCL6 transcriptional repressor
C Lemercier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression
G Lagger et al.
EMBO JOURNAL (2002)
Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence
E Langley et al.
EMBO JOURNAL (2002)
A microplate reader-based nonisotopic histone deacetylase activity assay
B Heltweg et al.
ANALYTICAL BIOCHEMISTRY (2002)
Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling
CF Deroanne et al.
ONCOGENE (2002)
Colorectal cancer in mice genetically deficient in the mucin Muc2
A Velcich et al.
SCIENCE (2002)
Negative control of p53 by Sir2α promotes cell survival under stress
JY Luo et al.
CELL (2001)
hSIR2SIRT1 functions as an NAD-dependent p53 deacetylase
H Vaziri et al.
CELL (2001)
ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain
JM Amann et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Histone deacetylase and DNA methyltransferase in human prostate cancer
SK Patra et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Duration of nuclear NF-κB action regulated by reversible acetylation
LF Chen et al.
SCIENCE (2001)
Genes modulated by histone acetylation as new effecters of butyrate activity
F Della Ragione et al.
FEBS LETTERS (2001)
Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes
MS Kim et al.
NATURE MEDICINE (2001)
Deacetylation of p53 modulates its effect on cell growth and apoptosis
JY Luo et al.
NATURE (2000)
Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation
VM Richon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Histone deacetylases specifically down-regulate p53-dependent gene activation
LJ Juan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The Rel/NF-κB family directly activates expression of the apoptosis inhibitor Bcl-xL
CL Chen et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
The ETO protein disrupted in t(8;21)-associated acute myeloid leukemia is a corepressor for the promyelocytic leukemia zinc finger protein
AM Melnick et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
分享论文
